As of 2025-09-17, the Relative Valuation of Recursion Pharmaceuticals Inc (RXRX) is (19.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.84 USD, the upside of Recursion Pharmaceuticals Inc based on Relative Valuation is -511.6%.
The range of the Relative Valuation is (20.51) - (19.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 13.8x | 13.8x |
| Forward P/E multiples | 12.5x - 13.3x | 12.9x |
| Fair Price | (20.51) - (19.92) | (19.92) |
| Upside | -523.8% - -511.5% | -511.6% |
| Date | P/E |
| 2025-09-16 | -3.24 |
| 2025-09-15 | -3.19 |
| 2025-09-12 | -3.23 |
| 2025-09-11 | -3.24 |
| 2025-09-10 | -3.04 |
| 2025-09-09 | -3.14 |
| 2025-09-08 | -3.09 |
| 2025-09-05 | -3.08 |
| 2025-09-04 | -3.02 |
| 2025-09-03 | -3.10 |
| 2025-09-02 | -3.12 |
| 2025-08-29 | -3.14 |
| 2025-08-28 | -3.25 |
| 2025-08-27 | -3.27 |
| 2025-08-26 | -3.23 |
| 2025-08-25 | -3.23 |
| 2025-08-22 | -3.30 |
| 2025-08-21 | -3.20 |
| 2025-08-20 | -3.19 |
| 2025-08-19 | -3.40 |
| 2025-08-18 | -3.69 |
| 2025-08-15 | -3.86 |
| 2025-08-14 | -3.77 |
| 2025-08-13 | -3.81 |
| 2025-08-12 | -3.62 |
| 2025-08-11 | -3.54 |
| 2025-08-08 | -3.58 |
| 2025-08-07 | -3.62 |
| 2025-08-06 | -3.67 |
| 2025-08-05 | -3.70 |
| 2025-08-04 | -3.88 |
| 2025-08-01 | -3.80 |
| 2025-07-31 | -3.98 |
| 2025-07-30 | -3.89 |
| 2025-07-29 | -3.98 |
| 2025-07-28 | -4.22 |
| 2025-07-25 | -4.34 |
| 2025-07-24 | -4.19 |
| 2025-07-23 | -4.30 |
| 2025-07-22 | -4.37 |
| 2025-07-21 | -4.28 |
| 2025-07-18 | -3.91 |
| 2025-07-17 | -3.69 |
| 2025-07-16 | -3.60 |
| 2025-07-15 | -3.49 |
| 2025-07-14 | -3.53 |
| 2025-07-11 | -3.53 |
| 2025-07-10 | -3.82 |
| 2025-07-09 | -3.74 |
| 2025-07-08 | -3.58 |